Satu L.
- Country
- Finland
- Department
- Medical Oncology
Research Overview
- Phase 3 Study of Busulfan, Melphalan, and Chemoimmunotherapy in High-Risk Neuroblastoma Patients with Insufficient Metastatic Response
- Evaluation of Chemotherapy Regimens Including Cisplatin, Cyclophosphamide, and Etoposide in Pediatric and Young Adult Ependymoma Treatment
- Phase 3 Randomized Trial of Tovorafenib Monotherapy vs. Standard Chemotherapy in Pediatric Low-Grade Glioma with RAF Alteration
Data & Insights
Has run more than one trial at 116 of 226 partner sites.
Specializations
Pediatric Neuro-Oncology
This investigator specializes in treating complex pediatric brain tumors, with particular expertise in ependymoma management across different WHO grades, including cellular, papillary, myxopapillary, clear-cell, tanycytic, and anaplastic variants.
- Intracranial Tumors
- Spinal Tumors
- Post-operative Care
The investigator focuses on integrating advanced imaging techniques with surgical interventions to optimize treatment outcomes.
Rare Pediatric Brain Tumors
The investigator has dedicated expertise in treating atypical teratoid/rhabdoid tumors (ATRT), a rare and aggressive form of brain cancer affecting young children. Their work encompasses comprehensive treatment approaches across different age groups.
- Infant Brain Tumors
- High-Dose Chemotherapy
- Consolidation Therapy
Their therapeutic approach is tailored to specific age groups, recognizing the unique challenges in treating very young patients.
Low-Grade Glioma Treatment
The investigator specializes in treating pediatric low-grade gliomas with a focus on tumors harboring RAF alterations. Their expertise includes evaluating novel targeted therapies against conventional treatment approaches.
- Targeted Therapy
- First-line Systemic Treatment
- Response Assessment
Their work involves implementing precision medicine approaches in pediatric brain tumor treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.